References
- Andersen, P. K., Borgan, Ø., Gill, R. D., and Keiding, N. (1993), Statistical Models Based on Counting Processes, New York: Springer.
- Basu, D. (1955), “On Statistics Independent of a Complete Sufficient Statistic,” Sankhyā: The Indian Journal of Statistics (1933-1960), 15, 377–380.
- Belin, L., De Rycke, Y., and Broët, P. (2017), “A Two-Stage Design for Phase II Trials with Time-to-Event Endpoint Using Restricted Follow-up,” Contemporary Clinical Trials Communications, 8, 127–134. DOI: 10.1016/j.conctc.2017.09.010.
- Breslow, N. E. (1975), “Analysis of Survival Data Under the Proportional Hazards Model,” International Statistical Review/Revue Internationale de Statistique, 43, 45–57. DOI: 10.2307/1402659.
- Chu, C., Liu, S., and Rong, A. (2020), “Study Design of Single-Arm Phase II Immunotherapy Trials with Long-Term Survivors and Random Delayed Treatment Effect,” Pharmaceutical Statistics, 19, 358–369. DOI: 10.1002/pst.1976.
- Danzer, M. F., Terzer, T., Berthold, F., Faldum, A., and Schmidt, R. (2022), “Confirmatory Adaptive Group Sequential Designs for Single-Arm Phase II Studies with Multiple Time-to-Event Endpoints,” Biometrical Journal, 64, 312–342. DOI: 10.1002/bimj.202000205.
- Díaz-Francés, E., and Rubio, F. J. (2013), “On the Existence of a Normal Approximation to the Distribution of the Ratio of Two Independent Normal Random Variables,” Statistical Papers, 54, 309–323. DOI: 10.1007/s00362-012-0429-2.
- Erdmann, F., Kaatsch, P., Grabow, D., and Spix, C. (2020), German Childhood Cancer Registry - Annual Report 2019 (1980-2018),” Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) at the University Medical Center of the Johannes Gutenberg University Mainz.
- Finkelstein, D. M., Muzikansky, A., and Schoenfeld, D. A. (2003), “Comparing Survival of a Sample to That of a Standard Population,” JNCI: Journal of the National Cancer Institute, 95, 1434–1439. DOI: 10.1093/jnci/djg052.
- Fleming, T. R., and Harrington, D. P. (2005), Counting Processes and Survival Analysis, Chichester: Wiley.
- Hinkley, D. V. (1969), “On the Ratio of Two Correlated Normal Random Variables,” Biometrika, 56, 635–639. DOI: 10.1093/biomet/56.3.635.
- Ivanova, A., Paul, B., Marchenko, O., Song, G., Patel, N., and Moschos, S. J. (2016), “Nine-Year Change in Statistical Design, Profile, and Success Rates of Phase II Oncology Trials,” Journal of Biopharmaceutical Statistics, 26, 141–149. DOI: 10.1080/10543406.2015.1092030.
- Kaatsch, P. (2004), “Das deutsche kinderkrebsregister im umfeld günstiger rahmenbedingungen,” Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 47, 437–443. DOI: 10.1007/s00103-004-0829-0.
- Kwak, M., and Jung, S.-H. (2014), “Phase II Clinical Trials with Time-to-Event Endpoints: Optimal Two-Stage Designs with One-Sample Log-Rank Test,” Statistics in Medicine, 33, 2004–2016. DOI: 10.1002/sim.6073.
- Ly, S., Pho, K.-H., Ly, S., and Wong, W.-K. (2019), “Determining Distribution for the Quotients of Dependent and Independent Random Variables by Using Copulas,” Journal of Risk and Financial Management, 12, 42. DOI: 10.3390/jrfm12010042.
- Nadarajah, S. (2006), “On the Ratio x/y for Some Elliptically Symmetric Distributions,” Journal of Multivariate Analysis, 97, 342–358. DOI: 10.1016/j.jmva.2005.03.004.
- NCSS, LLC. Kaysville, U. U. (2021). PASS 2021.
- R Core Team (2021), R: A Language and Environment for Statistical Computing, Vienna, Austria: R Foundation for Statistical Computing.
- Schmidt, R., Faldum, A., and Kwiecien, R. (2018), “Adaptive Designs for the One-sample Log-Rank Test,” Biometrics, 74, 529–537. DOI: 10.1111/biom.12776.
- Shan, G., and Zhang, H. (2019), “Two-Stage Optimal Designs with Survival Endpoint When the Follow-up Time is Restricted,” BMC Medical Research Methodology, 19, 74. DOI: 10.1186/s12874-019-0696-x.
- “Statsols” (Statistical Solutions Ltd.), Cork, I. (2017). nQuery.
- Stute, W. (1995), “The Statistical Analysis of Kaplan-Meier Integrals,” in Institute of Mathematical Statistics Lecture Notes – Monograph Series, pp. 231–254. Institute of Mathematical Statistics.
- Sun, X., Peng, P., and Tu, D. (2011), “Phase II Cancer Clinical Trials with a One-Sample Log-Rank Test and its Corrections Based on the Edgeworth Expansion,” Contemporary Clinical Trials, 32, 108–113. DOI: 10.1016/j.cct.2010.09.009.
- Therneau, T. M. (2021), A Package for Survival Analysis in R, R package version 3.2-13.
- Tu, D., and Gross, A. J. (1996), “A Bartlett-Type Correction for the Subject-Years Method in Comparing Survival Data to a Standard Population,” Statistics & Probability Letters, 29, 149–157.
- Wu, J. (2014), “A New One-sample Log-rank Test,” Journal of Biometrics & Biostatistics, 5, 1–5.
- Wu, J. (2015), “Sample Size Calculation for the One-Sample Log-Rank Test,” Pharmaceutical Statistics, 14, 26–33.
- Wu, J. (2016), “Single-arm Phase II Cancer Survival Trial Designs,” Journal of Biopharmaceutical Statistics, 26, 644–656.